Retinal Thickness and Morphology Changes on OCT in Youth with Type 2 Diabetes: Findings from the TODAY Study

• Published in: Ophthalmology science (Online) 2022-12, Vol.2 (4), p.100191-100191
• Main Authors: Mititelu, Mihai, Uschner, Diane, Doherty, Lindsay, Bjornstad, Petter, Domalpally, Amitha, Drews, Kimberly L, Gubitosi-Klug, Rose, Levitsky, Lynne L, Pak, Jeong W, White, Neil H, Blodi, Barbara A
• Format: Article
• Language: English
• Subjects: Original
• ISSN: 2666-9145
• DOI: 10.1016/j.xops.2022.100191

To evaluate changes in retinal thickness and morphology using OCT in youth with type 2 diabetes (T2D) and to identify systemic biomarkers correlating with these changes. Retrospective subgroup analysis of a prospective study. Participants who underwent OCT imaging in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) trial and its follow-up study TODAY2. In 2010-2011 (TODAY) and 2017-2018 (TODAY2), 6 × 6-mm macular volume OCT scans were acquired, segmented, and analyzed to generate total retinal thickness, inner retinal thickness, and outer retinal thickness. The main retinal morphologies graded were intraretinal cystoid spaces, subretinal fluid, and posterior vitreous detachment (PVD). Changes in total and individual retinal layer thickness and development of abnormal vitreomacular morphology between TODAY and TODAY2. Participants had a mean age of 17.9 ± 2.4 years and glycated hemoglobin (HbA1c) of 8.2 ± 2.8% in TODAY and a mean age of 25.0 ± 2.4 years and mean HbA1c of 9.5 ± 2.8% in TODAY2. Longitudinally between assessments, there were overall decreases in outer retinal thickness from 167.2 ± 11.5 microns to 158.4 ± 12.8 microns (